NGNE
Neurogene·NASDAQ
--
--(--)
--
--(--)
4.94 / 10
Netural
Fund flow momentum is favorable with a score of 7.65/10, reflecting robust capital inflow, particularly at the small-cap level. However, block and larger-sized flows show negative trends, suggesting potential profit-taking. Analyst consensus is overwhelmingly bullish (Strong Buy/Buy at 100% combined), yet historical win rates are only 50%, indicating limited predictive reliability. Together, the analyst and fund flow aspects present a mixed but slightly positive outlook.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
50%
Buy
50%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-13
InstitutionHC Wainwright & Co.
Times predicted4
Historical Win Rate50.0%
What is the analyst consensus for NGNE?
- NGNE holds a Bearish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.94/10 (Netural).
